Hong Kong · Delayed Price · Currency is HKD Genscript Biotech Statistics
Total Valuation
HKG:1548 has a market cap or net worth of HKD 69.28 billion. The enterprise value is 65.66 billion.
| Market Cap | 69.28B |
| Enterprise Value | 65.66B |
Important Dates
The next estimated earnings date is Monday, November 16, 2026.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1548 has 2.28 billion shares outstanding. The number of shares has decreased by -0.75% in one year.
| Current Share Class | 2.28B |
| Shares Outstanding | 2.28B |
| Shares Change (YoY) | -0.75% |
| Shares Change (QoQ) | -2.00% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 42.40% |
| Float | 1.48B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 71.18 |
| PS Ratio | 10.46 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | 183.82 |
| P/OCF Ratio | 63.30 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 174.22 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.53 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.68 |
| Debt / FCF | 7.15 |
| Interest Coverage | 8.68 |
Financial Efficiency
Return on equity (ROE) is -15.33% and return on invested capital (ROIC) is 3.67%.
| Return on Equity (ROE) | -15.33% |
| Return on Assets (ROA) | 1.54% |
| Return on Invested Capital (ROIC) | 3.67% |
| Return on Capital Employed (ROCE) | 3.10% |
| Weighted Average Cost of Capital (WACC) | 9.09% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | -813,880 |
| Employee Count | 6,135 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 9.65 |
Taxes
In the past 12 months, HKG:1548 has paid 371.48 million in taxes.
| Income Tax | 371.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.04% in the last 52 weeks. The beta is 0.92, so HKG:1548's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +77.04% |
| 50-Day Moving Average | 36.32 |
| 200-Day Moving Average | 20.57 |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 46,965,509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1548 had revenue of HKD 6.63 billion and -4.99 billion in losses. Loss per share was -2.29.
| Revenue | 6.63B |
| Gross Profit | 3.44B |
| Operating Income | 985.78M |
| Pretax Income | -4.63B |
| Net Income | -4.99B |
| EBITDA | 1.51B |
| EBIT | 985.78M |
| Loss Per Share | -2.29 |
Balance Sheet
The company has 6.35 billion in cash and 2.69 billion in debt, with a net cash position of 3.66 billion or 1.61 per share.
| Cash & Cash Equivalents | 6.35B |
| Total Debt | 2.69B |
| Net Cash | 3.66B |
| Net Cash Per Share | 1.61 |
| Equity (Book Value) | 30.53B |
| Book Value Per Share | 13.94 |
| Working Capital | 3.04B |
Cash Flow
In the last 12 months, operating cash flow was 1.09 billion and capital expenditures -717.64 million, giving a free cash flow of 376.90 million.
| Operating Cash Flow | 1.09B |
| Capital Expenditures | -717.64M |
| Depreciation & Amortization | 525.20M |
| Net Borrowing | 153.96M |
| Free Cash Flow | 376.90M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 51.99%, with operating and profit margins of 14.88% and -75.35%.
| Gross Margin | 51.99% |
| Operating Margin | 14.88% |
| Pretax Margin | -69.81% |
| Profit Margin | -75.35% |
| EBITDA Margin | 22.80% |
| EBIT Margin | 14.88% |
| FCF Margin | 5.69% |
Dividends & Yields
HKG:1548 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.75% |
| Shareholder Yield | 0.75% |
| Earnings Yield | -7.53% |
| FCF Yield | 0.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for HKG:1548 is 45.43, which is 49.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 45.43 |
| Price Target Difference | 49.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 16.05% |
| EPS Growth Forecast (3Y) | 8.97% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1548 has an Altman Z-Score of 3.58 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.58 |
| Piotroski F-Score | 4 |